Welcome to LookChem.com Sign In|Join Free
  • or
11-PHENOXYUNDECANOIC ACID is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

7170-44-7

Post Buying Request

7170-44-7 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

7170-44-7 Usage

Uses

11-Phenoxyundecanoic Acid can be used to treat tuberculosis.

Check Digit Verification of cas no

The CAS Registry Mumber 7170-44-7 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 7,1,7 and 0 respectively; the second part has 2 digits, 4 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 7170-44:
(6*7)+(5*1)+(4*7)+(3*0)+(2*4)+(1*4)=87
87 % 10 = 7
So 7170-44-7 is a valid CAS Registry Number.
InChI:InChI=1/C17H26O3/c18-17(19)14-10-5-3-1-2-4-6-11-15-20-16-12-8-7-9-13-16/h7-9,12-13H,1-6,10-11,14-15H2,(H,18,19)/p-1

7170-44-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name 11-PHENOXYUNDECANOIC ACID

1.2 Other means of identification

Product number -
Other names 11-phenoxy-undecanoic acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:7170-44-7 SDS

7170-44-7Relevant academic research and scientific papers

4-DIMETHYLAMINOBUTYRIC ACID DERIVATIVES

-

Page/Page column 15, (2009/10/31)

This invention relates to novel 4-dimethylaminobutyric acid derivatives of the formula wherein A1, A2, R1, m and n are as defined in the description and in the claims, as well as pharmaceutically acceptable salts thereof. These compounds inhibit carnitine palmitoyl transferase (CPT) activity, in particular CPT2 activity, and can be used as medicaments in methods for the treatment of diseases modulated by CPT2 inhibitors.

Synthesis and vesicle formation from hybrid bolaphile/ amphiphile ion-pairs. Evidence of membrane property modulation by molecular design

Bhattacharya, Santanu,De Soma,Subramanian

, p. 7640 - 7651 (2007/10/03)

Four new hybrid (bolaphile/amphiphile) ion-pairs were synthesized. Electron microscopy indicated that each of these forms bilayer membranes upon dispersion in aqueous media. Membrane properties have also been examined by differential scanning calorimetry, microcalorimetry, temperature-dependent fluorescence anisotropy measurements, and UV-vis spectroscopy. The Tm values for the vesicular 1,2,3,4, and 5 were 38,12,85,31.3, and 41.6 °C, respectively. Interestingly the Tm values for 1 and 3 were found to depend on their concentration. The entrapment of small solute and the release capability have also been examined to demonstrate that these bilayers form enclosed vesicles. X-ray diffraction of the cast films has been performed to understand the nature and the thickness of these membrane organizations. The membrane widths ranged from 33 to 47 A. Finally, the above observations have been analyzed in light of the results obtained from molecular modeling studies. Thus we have demonstrated that membrane properties can be modulated by simple structural changes at the amphiphile level. It was shown that by judicious incorporation of central, isomeric, disubstituted aromatic units as structural anchors into different bolaphiles, one can modulate the properties of the resulting vesicles.

Modulation of vesicular properties by variation of shapes of bolaform counter ions in hybrid-ion paired surfactants

Bhattacharya, Santanu,De, Soma

, p. 1283 - 1284 (2007/10/03)

Four new vesicle-forming bolaphile/amphiphile ion pairs are synthesized; the bolaphile shapes in such hybrid systems strongly control their vesicular properties.

Method of treating lipidemia with aryloxyalkylaminobenzoic acids and esters

-

, (2008/06/13)

Aryloxyalkylaminobenzoic acids and esters as hypolipemic compounds.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 7170-44-7